Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04315883 · ClinicalTrials.gov registry record
Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
A clinical trial, sponsored by Nemours Children's Clinic.
- Terminated
- Registry status
- 3
- Enrollment target
NCT04315883 is a clinical trial that was terminated before completion, run by Nemours Children's Clinic. The registered enrollment target is 3 participants.
The verdict
NCT04315883 was terminated before completion, sponsored by Nemours Children's Clinic.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This study will be performed to evaluate the Clinical Outcomes and Quality of Life after Transarterial Radioembolization with Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults with Liver Tumors. The treatment and techniques used here are well established in adults. The purpose of this study is to evaluate: 1. the response to treatment and clinical outcomes of treatment with TARE Y-90 as part of standard therapy and 2. to assess the change in the patient's quality of life before, during and after treatment with TARE-Y90
Interventions
- BEHAVIORAL Quality of Life Assessment
- RADIATION Transarterial Radioembolization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-02-11 |
| Est. Completion | 2024-03-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04315883
The ClinicalTrials.gov registry entry for NCT04315883 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quality of Life Assessment is the first listed.
NCT04315883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04315883 about?
NCT04315883 is a clinical study titled "Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors". This study will be performed to evaluate the Clinical Outcomes and Quality of Life after Transarterial Radioembolization with Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults with Liver Tumors. The treatment and techniques used here are well established in adults. The purpose of thi...
What is the current status of trial NCT04315883?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2021-02-11. Estimated completion is 2024-03-28.
What interventions are being tested in trial NCT04315883?
The interventions under investigation include: Quality of Life Assessment (BEHAVIORAL), Transarterial Radioembolization (RADIATION).
Who is sponsoring clinical trial NCT04315883?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.